CHICAGO - Loeb & Loeb LLP won a major victory in the United States Court of Appeals for the Federal Circuit on behalf of Celsis In Vitro, Inc. (Celsis IVT). In a precedential opinion authored by Chief Judge Randall R. Rader, the Federal Circuit affirmed the district court’s grant of a preliminary injunction against CellzDirect Inc. and Invitrogen Corporation (now known as Life Technologies Corporation) for its infringement of Celsis IVT’s LiverpoolTM patent (U.S. Patent No. 7,604,929). The Federal Court held that U.S. District Court Judge Milton I. Shadur committed no abuse of discretion in finding that each of the four preliminary injunction factors favored Celsis IVT. Loeb & Loeb has represented Celsis IVT since the inception of this case, including during the preliminary injunction proceeding, and the case remains pending as Celsis In Vitro, Inc. v. CellzDirect et al., No. 10-cv-4053, in the U.S. District Court for the Northern District of Illinois.
Celsis IVT, a worldwide leader in life sciences products and services, is represented by patent litigator from Loeb & Loeb’s Chicago office, Adam G. Kelly.
Loeb & Loeb’s Patent Litigation and Counseling Group provides a full range of patent prosecution, licensing, litigation and strategic counseling services to clients from around the world in every technology field, including pharmaceuticals, medical devices, computer software, semiconductors, consumer products, mechanical devices, electronics and optics.